All In Biotech

Free tool

FAERS Monitor: Benzamycin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050557 or its brand name (Benzamycin, Benzoyl Peroxide, Erythromycin). Reports on generic versions are filed under their own applications.

Reports

162

Serious

83

51% of reports

Hospitalization

31

Death reported

4

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective19
  • inflammatory bowel disease18
  • colitis ulcerative15
  • depression14
  • anxiety11
  • product physical consistency issue11
  • colitis10
  • rash10
  • crohn^s disease9
  • off label use9
  • dry skin8
  • irritable bowel syndrome8
  • polyarteritis nodosa8
  • acne7
  • application site pain7

Reports by year received

View as table
YearReports
20043
20054
20061
20071
20082
20093
20107
201110
20127
20137
20144
20159
201620
201721
201816
201914
20209
20218
20222
20236
20243
20254
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,997 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
polyarteritis nodosaSignal81805.0914.012,503
product physical consistency issueSignal11258.6146.12,566
inflammatory bowel diseaseSignal18239.3154.74,031
irritable bowel syndromeSignal848.524.7326
colitis ulcerativeSignal1543.626.9583
application site painSignal741.320.0236
colitisSignal1034.318.8291
acneSignal712.05.860
depressionSignal148.04.880
dry skinSignal87.84.041
anxietySignal115.02.832
rashSignal103.01.611
drug ineffective191.91.27
off label use91.30.70
crohn^s disease90.00.01,043,313

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.